Cargando…
Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression
BACKGROUND: Tumor necrosis factor alpha (TNF-α) blockers are recognized as a risk factor for reactivation of granulomatous infections. Leishmaniasis has been associated with the use of these drugs, although few cases have been reported. METHODOLOGY: We performed a retrospective observational study i...
Autores principales: | Bosch-Nicolau, Pau, Ubals, Maria, Salvador, Fernando, Sánchez-Montalvá, Adrián, Aparicio, Gloria, Erra, Alba, Martinez de Salazar, Pablo, Sulleiro, Elena, Molina, Israel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742442/ https://www.ncbi.nlm.nih.gov/pubmed/31469834 http://dx.doi.org/10.1371/journal.pntd.0007708 |
Ejemplares similares
-
Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021) -
A case report of long treatment with Itraconazole in a patient with chronic Chagas disease
por: Bosch-Nicolau, Pau, et al.
Publicado: (2019) -
Changes in the microbiological diagnosis and epidemiology of cutaneous leishmaniasis in real-time PCR era: A six-year experience in a referral center in Barcelona
por: Silgado, Aroa, et al.
Publicado: (2021) -
Strongyloides stercoralis infection: A systematic review of endemic cases in Spain
por: Barroso, Maria, et al.
Publicado: (2019) -
Association Between Trypanosoma cruzi DNA in Peripheral Blood and Chronic Chagasic Cardiomyopathy: A Systematic Review
por: Bosch-Nicolau, Pau, et al.
Publicado: (2022)